TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
VERA

Vera Therapeutics Inc

Healthcare · Biotechnology

33.30$ +0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VERA
Line item 2019 2020 2021 2022 2023 2024 2025
– +913.8% +53.5% +56.9% +33.6% +273.5% +12.1%
– +1,422.0% +52.1% +52.3% +36.9% +278.6% +11.9%
– +1,579.3% +48.5% -45.5% +5.1% +102.8% +282.9%
– +1,579.3% +48.5% +43.9% +40.2% +298.7% +11.5%
– – – – – – -12.9%
– – – – – – –
– – – – – – –
– +243.2% -90.2% +285.2% +35.5% +6.3% +65.8%
– +127.0% +219.6% +232.9% -12.9% +13.8% +110.7%
– -98.4% – – -7.9% -39.1% -63.0%
– +165.8% +52.4% +765.8% -7.3% -31.1% +185.7%
– – – +404.0% +101.0% +1.6% +47.6%
– – – +10.5% +32.2% +467.6% +4.7%
– – – – – – –
– +8.3% +262.3% +97.8% +60.7% +29.5% +16.1%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?